Disparities of health that impact outcomes for patients with multiple myeloma

Disparities of health that impact outcomes for patients with multiple myeloma

Disparities of health that impact outcomes for patients with multiple myeloma


Dr. Anna Kozarova

University of Windsor


FUNDER: Katelyn Bedard Bone Marrow Association (KBBMA)

DURATION: 2024-2025

Related Programs:
Nucleus Cores:

Multiple myeloma (MM), a malignancy of plasma cells in the bone marrow, results in severe complications such as weakened bones, anemia, kidney problems, and comprised immunity. Despite advancements, the disease remains complex and incurable. Recent research indicates that treatment outcomes are significantly influenced by genetics, biological sex, gender, socioeconomic status, access to healthcare, and ethinicity. To address these issues, health disparities affecting successful bone marrow transplantation for MM patients in the Windsor-Essex region will be investigated. The initiative includes a systematic literature review and a comparison of local and global datasets to identify key factors influencing treatment success. Integrating global and local findings will refine treatment strategies and lead to actionable recommendations for enhancing transplant success in local patients. 

By identifying and addressing disparities in MM care, this project aims to improve tratment outcomes and enhance transplant succes for local patients. The insights gained will inform targeted interventions and policy changes, contributing to more equitable and effective treatment strategies in the Windsor-Essex region. 

Co-Investigators:

Karmanos Cancer Institute

  • Dr. Indryas Woldie

University of Windsor

  • Dr. John Hudson
  • Dr. Lisa Porter

Collaborators:

University of Windsor

  • Dr. Kathy Pfaff

Windsor Regional Hospital

  • Dr. Sahar Khan
Loading...